Unnamed: 0,title,date,stock,sentiment
1094818.0,P/E Ratio Insights for ResMed,2020-06-10 14:08:00-04:00,RMD,neutral
1094819.0,ResMed's Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort Inhaler to its Digital Health Platform,2020-05-26 08:11:00-04:00,RMD,neutral
1094820.0,"ResMed Highlights Launch Of ResMed MaskSelector, A Digital Tool To Help Make Remote Patient Mask Selection, Sizing Easier",2020-05-18 09:05:00-04:00,RMD,positive
1094821.0,"Oppenheimer Upgrades ResMed to Outperform, Announces $200 Price Target",2020-05-01 05:53:00-04:00,RMD,neutral
1094822.0,"ResMed Q3 Adj. EPS $1.290 Beats $1.030 Estimate, Sales $769.500M Beat $719.570M Estimate",2020-04-30 16:23:00-04:00,RMD,neutral
1094823.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,RMD,positive
1094824.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,RMD,negative
1094825.0,"Companies Cited In Trump Memo Are General Electric, Hill-Rom Holdings, Medtronic, Resmed, Royal Philips And Vyaire Medical",2020-04-02 15:39:00-04:00,RMD,neutral
1094826.0,"Tesla Can Help With Lithium-Ion Batteries For Its Ventilators, Says ResMed's CEO",2020-04-02 06:56:00-04:00,RMD,positive
1094827.0,Musk Says Tesla Has 'Extra' Ventilators Ready For Shipping,2020-03-31 12:10:00-04:00,RMD,positive
1094828.0,ResMed shares are trading higher following an uptick in global coronavirus cases. ResMed is a respiratory medical device company.,2020-03-30 09:01:00-04:00,RMD,positive
1094829.0,"ResMed Issues Statement On Coronavirus, Co Says Its Primary Focus Is To Maximize The Availability Of ResMed Ventilators And Other Respiratory Support Devices For The Patients That Need Them The Most",2020-03-23 16:19:00-04:00,RMD,positive
1094830.0,"Shares of several healthcare companies are trading lower as the coronavirus outbreak continues to cause economic disruption around the globe, leading to a steep selloff in equities across sectors.",2020-03-16 10:50:00-04:00,RMD,negative
1094831.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,RMD,negative
1094832.0,FDA Says ResMed Recalls Stellar 100 And 150 Non-invasive And Invasive Ventilators Due To Sound Alarm Failure; FDA Says Has Identified ResMed's Recall As Class 1 Recall,2020-02-19 11:59:00-05:00,RMD,negative
1094833.0,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA",2020-02-19 07:21:00-05:00,RMD,negative
1094834.0,Hearing Morgan Stanley Downgraded ResMed To Equal Weight,2020-02-18 14:07:00-05:00,RMD,neutral
1094835.0,Stocks That Hit 52-Week Highs On Friday,2020-02-14 10:15:00-05:00,RMD,neutral
1094836.0,"The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering",2020-02-14 08:23:00-05:00,RMD,negative
1094837.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-11 10:17:00-05:00,RMD,neutral
1094838.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,RMD,positive
1094839.0,Stocks That Hit 52-Week Highs On Monday,2020-02-10 10:25:00-05:00,RMD,neutral
1094840.0,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",2020-02-07 07:32:00-05:00,RMD,negative
1094841.0,"The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs",2020-02-06 07:47:00-05:00,RMD,negative
1094842.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-05 10:16:00-05:00,RMD,neutral
1094843.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,RMD,neutral
1094844.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-04 10:18:00-05:00,RMD,neutral
1094845.0,"Benzinga's Top Upgrades, Downgrades For February 3, 2020",2020-02-03 09:55:00-05:00,RMD,positive
1094846.0,CLSA Initiates Coverage On ResMed with Underperform Rating,2020-02-03 06:42:00-05:00,RMD,neutral
1094847.0,ResMed Subsidiary Brightree Reports Will Acquire SnapWorx To Expand Its CPAR Resuppy Offerings For HME Providers,2020-01-31 11:06:00-05:00,RMD,positive
1094848.0,10 Biggest Price Target Changes For Friday,2020-01-31 08:29:00-05:00,RMD,neutral
1094849.0,"UBS Downgrades ResMed to Neutral, Raises Price Target to $174",2020-01-31 07:16:00-05:00,RMD,neutral
1094850.0,"ResMed Q2 EPS $1.21 Beats $1.03 Estimate, Sales $736.2M Beat $731.58M Estimate",2020-01-30 16:08:00-05:00,RMD,neutral
1094851.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,RMD,positive
1094852.0,"The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment",2020-01-23 07:24:00-05:00,RMD,positive
1094853.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-22 10:17:00-05:00,RMD,neutral
1094854.0,"The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings",2020-01-22 08:25:00-05:00,RMD,neutral
1094855.0,Stocks That Hit 52-Week Highs On Friday,2020-01-17 13:23:00-05:00,RMD,neutral
1094856.0,"The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares",2020-01-17 08:07:00-05:00,RMD,negative
1094857.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-16 10:22:00-05:00,RMD,neutral
1094858.0,"The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics",2020-01-16 07:22:00-05:00,RMD,neutral
1094859.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-15 13:14:00-05:00,RMD,neutral
1094860.0,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug",2020-01-14 07:55:00-05:00,RMD,positive
1094861.0,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx",2020-01-10 07:13:00-05:00,RMD,positive
1094862.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-09 15:15:00-05:00,RMD,neutral
1094863.0,Stocks That Hit 52-Week Highs On Friday,2019-12-20 11:59:00-05:00,RMD,neutral
1094864.0,"The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",2019-12-19 07:52:00-05:00,RMD,negative
1094865.0,Stocks That Hit 52-Week Highs On Wednesday,2019-12-18 10:43:00-05:00,RMD,neutral
1094866.0,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",2019-12-18 07:23:00-05:00,RMD,positive
1094867.0,Stocks That Hit 52-Week Highs On Tuesday,2019-12-17 11:19:00-05:00,RMD,neutral
1094868.0,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",2019-12-17 07:56:00-05:00,RMD,positive
1094869.0,Stocks That Hit 52-Week Highs On Friday,2019-12-13 11:19:00-05:00,RMD,neutral
1094870.0,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",2019-12-13 08:10:00-05:00,RMD,positive
1094871.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-12 10:21:00-05:00,RMD,neutral
1094872.0,Stocks That Hit 52-Week Highs On Friday,2019-12-06 10:33:00-05:00,RMD,neutral
1094873.0,"Benzinga's Top Upgrades, Downgrades For November 22, 2019",2019-11-22 10:03:00-05:00,RMD,positive
1094874.0,KeyBanc Initiates Coverage On ResMed with Sector Weight Rating,2019-11-22 06:12:00-05:00,RMD,neutral
1094875.0,"The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon",2019-11-21 07:22:00-05:00,RMD,positive
1094876.0,Stocks That Hit 52-Week Highs On Wednesday,2019-11-20 10:12:00-05:00,RMD,neutral
1094877.0,Stocks That Hit 52-Week Highs On Friday,2019-11-01 10:31:00-04:00,RMD,neutral
1094878.0,"The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance",2019-11-01 07:38:00-04:00,RMD,neutral
1094879.0,"The Daily Biotech Pulse: Agile Receives Favorable Adcom Verdict, Merit Medical Tumbles On Earnings, 2 Biotechs To Debut",2019-10-31 08:08:00-04:00,RMD,positive
1094880.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,RMD,negative
1094881.0,51 Biggest Movers From Friday,2019-10-28 05:27:00-04:00,RMD,neutral
1094882.0,Stocks That Hit 52-Week Highs On Friday,2019-10-25 12:47:00-04:00,RMD,neutral
1094883.0,19 Stocks Moving In Friday's Mid-Day Session,2019-10-25 12:47:00-04:00,RMD,neutral
1094884.0,"The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug",2019-10-25 07:12:00-04:00,RMD,positive
1094885.0,"ResMed Q1 Adj. EPS $0.93 Beats $0.87 Estimate, Sales $681.1M Beat $660.66M Estimate",2019-10-24 16:46:00-04:00,RMD,neutral
1094886.0,"The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise",2019-10-24 07:36:00-04:00,RMD,neutral
1094887.0,"The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict",2019-10-20 08:08:00-04:00,RMD,positive
1094888.0,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,2019-10-11 11:19:00-04:00,RMD,positive
1094889.0,Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15.,2019-10-08 10:36:00-04:00,RMD,positive
1094890.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week.,2019-10-02 10:33:00-04:00,RMD,negative
1094891.0,"The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication",2019-09-06 07:27:00-04:00,RMD,neutral
1094892.0,"The Daily Biotech Pulse: Genmab-Novartis Multiple Sclerosis Drug Aces Late-Stage Studies, Akari Nets Orphan Drug Designation",2019-08-30 08:28:00-04:00,RMD,neutral
1094893.0,"The Daily Biotech Pulse: FDA Likes Nabriva's Antibiotic, Snubs Sarepta's DMD Drug; Moderna Gets Fast Track Designation For Zika Vaccine",2019-08-20 07:33:00-04:00,RMD,negative
1094894.0,"The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering",2019-08-14 07:50:00-04:00,RMD,negative
1094895.0,Stocks That Hit 52-Week Highs On Tuesday,2019-08-13 10:28:00-04:00,RMD,neutral
1094896.0,"Benzinga's Top Upgrades, Downgrades For July 29, 2019",2019-07-29 09:55:00-04:00,RMD,positive
1094897.0,Goldman Sachs Upgrades ResMed to Buy,2019-07-29 07:57:00-04:00,RMD,neutral
1094898.0,"UBS Upgrades ResMed to Buy, Raises Price Target to $140",2019-07-29 07:40:00-04:00,RMD,neutral
1094899.0,Companies That Achieved 52-Week Highs Friday,2019-07-26 15:37:00-04:00,RMD,neutral
1094900.0,ResMed shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. The company also raised its quarterly dividend.,2019-07-26 10:09:00-04:00,RMD,positive
1094901.0,ResMed Raises Qtr. Dividend From $0.37 To $0.39/Share,2019-07-25 16:47:00-04:00,RMD,neutral
1094902.0,"ResMed Q4 Adj. EPS $0.95 Beats $0.92 Estimate, Sales $705M Beat $701.95M Estimate",2019-07-25 16:47:00-04:00,RMD,neutral
1094903.0,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug",2019-07-25 07:21:00-04:00,RMD,negative
1094904.0,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,2019-07-20 09:53:00-04:00,RMD,neutral
1094905.0,"The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight",2019-07-05 08:55:00-04:00,RMD,negative
1094906.0,"The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug",2019-07-02 07:29:00-04:00,RMD,positive
1094907.0,"The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy",2019-06-21 07:18:00-04:00,RMD,negative
1094908.0,"The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge",2019-06-20 07:25:00-04:00,RMD,positive
1094909.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Tue., June 11, 2019",2019-06-11 13:14:00-04:00,RMD,positive
1094910.0,"Shares of several healthcare companies are trading higher as the US market rebounds from recent weakness, driven by renewed cautious optimism surrounding US-China trade talks.",2019-05-14 13:32:00-04:00,RMD,positive
1094911.0,"Benzinga's Top Upgrades, Downgrades For May 6, 2019",2019-05-06 09:11:00-04:00,RMD,positive
1094912.0,UBS Upgrades ResMed Inc. Common Stock to Buy,2019-05-06 06:22:00-04:00,RMD,neutral
1094913.0,80 Biggest Movers From Friday,2019-05-06 05:54:00-04:00,RMD,neutral
1094914.0,58 Stocks Moving In Friday's Mid-Day Session,2019-05-03 14:25:00-04:00,RMD,neutral
1094915.0,ResMed shares are trading higher after the company reported better-than-expected Q3 EPS and revenue results.,2019-05-03 08:46:00-04:00,RMD,positive
1094916.0,35 Stocks Moving In Friday's Pre-Market Session,2019-05-03 08:05:00-04:00,RMD,neutral
1094917.0,"ResMed Q3 Adj. EPS $0.89 Beats $0.86 Estimate, Sales $662.2M Beat $660.96M Estimate",2019-05-02 16:39:00-04:00,RMD,neutral
1094918.0,"Benzinga's Top Upgrades, Downgrades For April 18, 2019",2019-04-18 09:52:00-04:00,RMD,positive
1094919.0,JP Morgan Upgrades ResMed to Neutral,2019-04-18 08:46:00-04:00,RMD,positive
1094920.0,Shares of several medical device companies are trading lower with the healthcare sector. Healthcare has seen weakness recently due to concerns over the future of the Affordable Act under Trump and healthcare policy uncertainty ahead of the 2020 election.,2019-04-17 12:45:00-04:00,RMD,negative
1094921.0,Deutsche Bank Upgrades ResMed to Buy,2019-03-20 09:39:00-04:00,RMD,neutral
1094922.0,"ResMed Reports Purchase Of HB Healthcare, No Terms Disclosed",2019-03-07 17:31:00-05:00,RMD,negative
1094923.0,ResMed And Fisher & Paykel Healthcare Announce Settlement Of Global Patent Infringement Litigation; Settlement Involves No Payment Or Admission Of Liability From Either Side,2019-02-20 09:05:00-05:00,RMD,negative
1094924.0,55 Biggest Movers From Friday,2019-01-28 05:40:00-05:00,RMD,neutral
1094925.0,Mid-Afternoon Market Update: Lantronix Rises After Q2 Results; PG&E Shares Slide,2019-01-25 14:33:00-05:00,RMD,positive
1094926.0,35 Stocks Moving In Friday's Mid-Day Session,2019-01-25 12:32:00-05:00,RMD,neutral
1094927.0,Mid-Day Market Update: OSI Systems Surges Following Upbeat Earnings; ResMed Shares Plunge,2019-01-25 12:01:00-05:00,RMD,positive
1094928.0,Mid-Morning Market Update: Markets Open Higher; D. R. Horton Profit Misses Views,2019-01-25 10:15:00-05:00,RMD,positive
1094929.0,ResMed shares are trading lower after the company reported mixed Q2 earnings; JP Morgan subsequently downgraded the company's stock from 'Neutral' to 'Underweight',2019-01-25 09:26:00-05:00,RMD,positive
1094930.0,"Benzinga's Top Upgrades, Downgrades For January 25, 2019",2019-01-25 09:10:00-05:00,RMD,positive
1094931.0,21 Stocks Moving In Friday's Pre-Market Session,2019-01-25 08:03:00-05:00,RMD,neutral
1094932.0,JP Morgan Downgrades ResMed to Underweight,2019-01-25 08:00:00-05:00,RMD,positive
1094933.0,ResMed shares are trading lower after hours following a Q2 sales miss.,2019-01-24 17:07:00-05:00,RMD,negative
1094934.0,9 Stocks Moving In Thursday's After-Hours Session,2019-01-24 17:00:00-05:00,RMD,neutral
1094935.0,ResMed Temporarily Suspends Buyback Program Due To Recent Acquisitions,2019-01-24 16:28:00-05:00,RMD,neutral
1094936.0,"ResMed Q2 Adj. EPS $1.00 Beats $0.94 Estimate, Sales $651.1M Miss $669.66M Estimate",2019-01-24 16:28:00-05:00,RMD,negative
1094937.0,"Earnings Scheduled For January 24, 2019",2019-01-24 04:28:00-05:00,RMD,neutral
1094938.0,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",2019-01-17 08:06:00-05:00,RMD,positive
1094939.0,"ResMed Subsidiary, Brightree, Acquires Mobile Delivery Provider Apacheta To Streamline HME Delivery; Financial Terms Not Disclosed",2018-12-17 09:05:00-05:00,RMD,neutral
1094940.0,"Benzinga's Top Upgrades, Downgrades For December 10, 2018",2018-12-10 09:51:00-05:00,RMD,positive
1094941.0,"BMO Capital Upgrades ResMed to Outperform, Raises Price Target to $127",2018-12-10 08:19:00-05:00,RMD,neutral
1094942.0,"Safeguard Scientifics Partner Company, Propeller Health, To Be Acquired For $225M By ResMed",2018-12-03 09:16:00-05:00,RMD,positive
1094943.0,ResMed Reports Purchase Of Propeller Health For $225M,2018-12-03 09:06:00-05:00,RMD,neutral
1094944.0,"Stocks That Will Trade Ex Dividend For Wed., Nov. 7, 2018",2018-11-06 09:25:00-05:00,RMD,neutral
1094945.0,ResMed To Acquire MatrixCare For $750M,2018-11-05 09:13:00-05:00,RMD,neutral
1094946.0,"ResMed Q1 EPS $1.23 Beats $0.80 Estimate, Sales $614.832M Beat $572.12M Estimate",2018-10-25 16:57:00-04:00,RMD,neutral
1094947.0,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",2018-10-25 08:03:00-04:00,RMD,negative
1094948.0,UPDATE: ResMed Says 'Court finds headgear used on Simplus and Eson 2 CPAP masks infringes ResMed patent',2018-10-22 16:32:00-04:00,RMD,neutral
1094949.0,ResMed Reports Won German Patent Infringement Case Against Fisher & Paykel,2018-10-22 16:32:00-04:00,RMD,positive
1094950.0,"The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs",2018-10-21 17:15:00-04:00,RMD,neutral
1094951.0,ResMed Announces AirFit F30 CPAP Mask Now Available In U.S. And Canada,2018-10-15 09:06:00-04:00,RMD,neutral
1094952.0,"Stocks Which Set New 52-Week High Yesterday, October 1st",2018-10-02 09:20:00-04:00,RMD,neutral
1094953.0,"The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares",2018-10-02 09:10:00-04:00,RMD,positive
1094954.0,"Stocks Which Set New 52-Week High Yesterday, September 26th",2018-09-27 09:12:00-04:00,RMD,neutral
1094955.0,"The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron",2018-09-27 08:20:00-04:00,RMD,neutral
1094956.0,"Stocks Which Set New 52-Week High Yesterday, September 25th",2018-09-26 11:53:00-04:00,RMD,neutral
1094957.0,"The Daily Biotech Pulse: Verastem's Chinese Duvelisib Licensing Deal, Aldeyra's Positive Dry Eye Disease Drug Trial",2018-09-26 08:25:00-04:00,RMD,positive
1094958.0,"Stocks Which Set New 52-Week High Friday, September 21",2018-09-24 09:43:00-04:00,RMD,neutral
1094959.0,"Stocks Which Set New 52-Week High Yesterday, September 17th",2018-09-18 09:25:00-04:00,RMD,neutral
1094960.0,"The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares",2018-09-18 08:44:00-04:00,RMD,positive
1094961.0,"Stocks Which Set New 52-Week High Friday, September 14th",2018-09-17 09:28:00-04:00,RMD,neutral
1094962.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,RMD,neutral
1094963.0,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",2018-09-14 08:38:00-04:00,RMD,neutral
1094964.0,"Stocks Which Set New 52-Week High Friday, September 7th",2018-09-10 16:36:00-04:00,RMD,neutral
1094965.0,ResMed Files Patent Infringement Action Against Fisher & Paykel; Case Asserts F&P's Simplus And Eson Infringe Upon ResMed Patents,2018-08-31 16:06:00-04:00,RMD,negative
1094966.0,"Stocks Which Set New 52-Week High Yesterday, August 30th",2018-08-31 10:11:00-04:00,RMD,neutral
1094967.0,"The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage",2018-08-31 08:29:00-04:00,RMD,positive
1094968.0,"Stocks Which Set New 52-Week High Yesterday, August 29th",2018-08-30 11:47:00-04:00,RMD,neutral
1094969.0,"The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",2018-08-30 08:02:00-04:00,RMD,neutral
1094970.0,"Stocks Which Set New 52-Week High Yesterday, August 28th",2018-08-29 11:13:00-04:00,RMD,neutral
1094971.0,"The Daily Biotech Pulse: Assertio Settles With Purdue, Emergent Biosolutions In M&A Mix, Novartis Eye Care Unit Recalls Stent",2018-08-29 07:54:00-04:00,RMD,positive
1094972.0,"The Daily Biotech Pulse: Regulatory Roadblock For Akcea-Ionis, Affimed's Alliance, FDA Nod For Tetraphase's Antibiotic",2018-08-28 08:13:00-04:00,RMD,neutral
1094973.0,"ResMed Q4 EPS $0.95 Beats $0.94 Estimate, Sales $623.6M Beat $621.34M Estimate",2018-08-02 16:54:00-04:00,RMD,neutral
1094974.0,"The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter",2018-08-02 08:54:00-04:00,RMD,positive
1094975.0,"Earnings Scheduled For August 2, 2018",2018-08-02 04:48:00-04:00,RMD,neutral
1094976.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs",2018-07-28 14:04:00-04:00,RMD,neutral
1094977.0,Stocks Which Set New 52-Week Highs Friday,2018-07-23 11:08:00-04:00,RMD,neutral
1094978.0,"Benzinga's Daily Biotech Pulse: Novartis Licenses Skin Drug, 2 Stocks To Debut",2018-07-19 09:14:00-04:00,RMD,neutral
1094979.0,"Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares",2018-07-18 08:42:00-04:00,RMD,positive
1094980.0,"Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares",2018-07-11 08:15:00-04:00,RMD,neutral
1094981.0,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",2018-06-14 08:11:00-04:00,RMD,negative
1094982.0,"Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs",2018-06-08 09:20:00-04:00,RMD,positive
1094983.0,"Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study",2018-06-07 07:58:00-04:00,RMD,neutral
1094984.0,"ResMed to Acquire HEALTHCAREfirst, Terms Not Disclosed",2018-05-29 09:05:00-04:00,RMD,neutral
1094985.0,"ResMed Q3 Adj. EPS $0.92 Beats $0.84 Est., Sales $591.6M Beats $574M Est.",2018-04-26 17:09:00-04:00,RMD,neutral
1094986.0,Citigroup Downgrades ResMed to Neutral,2018-04-04 10:05:00-04:00,RMD,neutral
1094987.0,40 Biggest Movers From Yesterday,2018-01-24 05:38:00-05:00,RMD,neutral
1094988.0,Mid-Afternoon Market Update: Crude Oil Up 1.4%; ResMed Shares Rise On Earnings Beat,2018-01-23 14:41:00-05:00,RMD,negative
1094989.0,ResMed Shares Up ~16% Following Earlier Needham Upgrade,2018-01-23 14:17:00-05:00,RMD,positive
1094990.0,33 Stocks Moving In Tuesday's Mid-Day Session,2018-01-23 12:50:00-05:00,RMD,neutral
1094991.0,Mid-Day Market Update: Netflix Climbs Following Q4 Results; Insmed Shares Plummet,2018-01-23 12:04:00-05:00,RMD,positive
1094992.0,Mid-Morning Market Update: Markets Mixed; Johnson & Johnson Beats Q4 Views,2018-01-23 10:09:00-05:00,RMD,neutral
1094993.0,Needham Upgrades ResMed to Hold,2018-01-23 08:49:00-05:00,RMD,neutral
1094994.0,11 Stocks Moving In Monday's After-Hours Session,2018-01-22 17:35:00-05:00,RMD,neutral
1094995.0,"ResMed Reports Q2 Adj. ESP $1 vs $0.78 Est., Sales $601.273M vs $580.32M Est.",2018-01-22 16:07:00-05:00,RMD,neutral
1094996.0,"Earnings Scheduled For January 22, 2018",2018-01-22 04:09:00-05:00,RMD,neutral
1094997.0,ResMed Says Considering Appeal in UK Patent Case with Fisher & Paykel,2017-11-12 17:27:00-05:00,RMD,neutral
1094998.0,"ResMed Q1 Adj. EPS $0.66 vs $0.66 Est., Sales $523.66M vs $505.61M Est.",2017-10-26 16:08:00-04:00,RMD,neutral
1094999.0,"ResMed Wins German Patent Infringement Case Brought by Fisher & Paykel, Ruling Has No Impact On Resmed and Fisher & Paykel's Patent Infringement Litigation In Other Jurisdictions",2017-10-12 09:48:00-04:00,RMD,negative
1095000.0,ResMed Announces Updates in Ongoing Global Patent Infringement Litigation with Fisher & Paykel,2017-10-06 05:59:00-04:00,RMD,negative
1095001.0,Hearing A German Court Has Suspended Patent Proceedings Brought By ResMed Against Fisher & Paykel Healthcare,2017-09-28 16:28:00-04:00,RMD,negative
1095002.0,"Companies Holding Shareholder Meetings Today Include: Digital Ally, Interleukin Genetics, and ResMed",2017-08-14 08:33:00-04:00,RMD,neutral
1095003.0,18 Biggest Mid-Day Losers For Wednesday,2017-08-02 12:52:00-04:00,RMD,negative
1095004.0,"Benzinga's Top Upgrades, Downgrades For August 2, 2017",2017-08-02 09:24:00-04:00,RMD,positive
1095005.0,Citigroup Upgrades ResMed to Buy,2017-08-02 08:53:00-04:00,RMD,neutral
1095006.0,Bank of America Downgrades ResMed to Neutral,2017-08-02 08:15:00-04:00,RMD,neutral
1095007.0,Credit Suisse Downgrades ResMed to Neutral,2017-08-02 08:15:00-04:00,RMD,positive
1095008.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-08-02 08:14:00-04:00,RMD,neutral
1095009.0,"ResMed Reports Q4 EPS $0.77 vs. $0.75 Est., Sales $556.7M vs. $555.73M Est.",2017-08-01 16:09:00-04:00,RMD,neutral
1095010.0,Watch These 5 Huge Call Purchases In Monday Trade,2017-07-24 03:50:00-04:00,RMD,positive
1095011.0,Benzinga's Option Alert Recap From July 21,2017-07-21 16:12:00-04:00,RMD,positive
1095012.0,Resmed Option Alert: Aug 18 $85 Calls at the Ask: 850 @ $0.6 vs 7 OI; Ref=$76.91,2017-07-21 13:53:00-04:00,RMD,positive
1095013.0,"UPDATE: ResMed, Packaging Corp. Of America, AO Smith, Duke Realty To Replace Mallinckrodt, Murphy Oil, Bed Bath & Beyond, Transocean In S&P 500",2017-07-19 17:18:00-04:00,RMD,neutral
1095014.0,"S&P Dow Jones Indices Announces 'MGM Resorts, ResMed, Packaging Corporation of
America, A.O. Smith and Duke Realty Set to Join S&P 500; Others to Join S&P MidCap 400'",2017-07-19 17:17:00-04:00,RMD,positive
1095015.0,"ResMed Reports Wholly-Owned Subsidiary, Brightree, Purchased AllCall Connect, No Terms Disclosed",2017-07-05 09:04:00-04:00,RMD,negative
1095018.0,"ResMed Reports Brightree Purchased Conduit Technology, No Terms Disclosed",2017-06-05 09:09:00-04:00,RMD,negative
1095019.0,Resmed Announces Clinical Trial Published in JAMA Offers New Hope for COPD Patients PRN,2017-05-21 10:16:00-04:00,RMD,positive
1095020.0,"ResMed Q3 EPS $0.71 vs $0.71 Est, Sales $514.2M vs $519.9M Est",2017-04-27 16:51:00-04:00,RMD,neutral
1095021.0,"Northland Out Negative On ResMed, Regarding Rebid Delay, Says They Do Not Think It Is Prudent To Get Too Excited With This Temporary Delay",2017-02-08 10:30:00-05:00,RMD,negative
1095022.0,20 Biggest Mid-Day Gainers For Tuesday,2017-01-24 12:39:00-05:00,RMD,neutral
1095023.0,"Benzinga's Top Upgrades, Downgrades For January 24, 2017",2017-01-24 09:23:00-05:00,RMD,positive
1095024.0,JP Morgan Upgrades ResMed To Overweight,2017-01-24 08:19:00-05:00,RMD,neutral
1095025.0,"ResMed Reports Q2 EPS $0.73 vs. Est. $0.70, Rev. $530.4M vs. Est. $515M",2017-01-23 16:05:00-05:00,RMD,neutral
1095026.0,"Earnings Scheduled For January 23, 2017",2017-01-23 04:52:00-05:00,RMD,neutral
1095027.0,ResMed's Announces European Research Shows myAir Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea,2017-01-12 04:03:00-05:00,RMD,positive
1095028.0,ResMed Gets FDA Clearance for AirMini,2017-01-09 09:02:00-05:00,RMD,neutral
1095029.0,Hearing Morgan Stanley Has Added ResMed Shares to Its 'Long Tactical Idea' List,2016-11-08 11:10:00-05:00,RMD,positive
1095030.0,ResMed Introduces AirFit N20 and AirFit F20 CPAP Masks: A New Standard for Fit and Comfort,2016-11-01 09:04:00-04:00,RMD,positive
1095031.0,Fichthorn Says on CNBC He's Shorting ResMed and Exact Sciences,2016-10-27 12:58:00-04:00,RMD,neutral
1095032.0,"ResMed Reports Q1 EPS $0.62 vs. Est. $0.64, Rev. $465.4M vs. Est. $474.7M",2016-10-25 16:06:00-04:00,RMD,neutral
1095033.0,ResMed Boosted To Buy At Bank Of America,2016-09-29 12:34:00-04:00,RMD,positive
1095034.0,Bank of America Upgrades ResMed to Buy,2016-09-29 09:48:00-04:00,RMD,neutral
1095035.0,JP Morgan Downgrades ResMed to Neutral,2016-09-19 11:22:00-04:00,RMD,positive
1095036.0,Hearing JP Morgan Downgraded ResMed from Overweight to Neutral,2016-09-19 11:15:00-04:00,RMD,neutral
1095037.0,Rising Street Value Of ResMed Shares Disconnected From Its Fundamentals,2016-08-25 11:30:00-04:00,RMD,positive
1095038.0,15 Biggest Mid-Day Losers For Tuesday,2016-08-23 13:07:00-04:00,RMD,negative
1095039.0,Benzinga's Top Downgrades,2016-08-23 09:12:00-04:00,RMD,positive
1095040.0,"The Market In 5 Minutes: S&P And Dow Unchanged, Monsanto Takeover Talks Heat Up Again",2016-08-23 08:54:00-04:00,RMD,neutral
1095041.0,Jefferies Downgrades ResMed to Underperform,2016-08-23 06:32:00-04:00,RMD,neutral
1095042.0,ResMed Takes Fisher & Paykel to Court over Patents,2016-08-17 17:11:00-04:00,RMD,neutral
1095043.0,"10 Notable Stocks Trading Ex-Dividend Tuesday, August 16",2016-08-15 13:39:00-04:00,RMD,neutral
1095044.0,"ResMed Reports Q4 Adj. EPS $0.74, Inline, Sales $518.6M vs $514M Est.",2016-07-28 16:10:00-04:00,RMD,neutral
1095045.0,"ResMed Reports Winning of Purchasing Contract with Premier, No Terms Disclosed",2016-06-28 09:02:00-04:00,RMD,positive
1095046.0,Needham Downgrades ResMed To Underperform,2016-06-27 08:04:00-04:00,RMD,neutral
1095047.0,Needham Downgrades ResMed from Hold to Underperform,2016-06-27 07:33:00-04:00,RMD,neutral
1095048.0,UPDATE: ResMed Says Brightree Will Continue to Operate as Separate Entity,2016-06-20 09:02:00-04:00,RMD,neutral
1095049.0,"UPDATE: ResMed Highlights Brightree's Current Pres, CEO Cormack to Transition Into Multi-Year Advisory Role",2016-06-20 09:02:00-04:00,RMD,neutral
1095050.0,"ResMed Offers Statement on Brightree Naming Matt Mellott CEO, Bobby Ghoshal COO",2016-06-20 09:01:00-04:00,RMD,neutral
1095051.0,ResMed Reports ITC Will Investigate BMC Medical's Infringement of Co. Patents,2016-05-13 06:04:00-04:00,RMD,negative
1095052.0,The Market In 5 Minutes: Thumbs Up,2016-04-28 10:36:00-04:00,RMD,neutral
1095053.0,Benzinga's Top Upgrades,2016-04-28 09:20:00-04:00,RMD,positive
1095054.0,Macquarie Upgrades ResMed to Neutral,2016-04-28 07:15:00-04:00,RMD,neutral
1095055.0,"Piper Jaffray Downgrades ResMed to Neutral, Lowers PT to $57.00",2016-04-27 07:07:00-04:00,RMD,negative
1095056.0,"ResMed Reports Q3 Adj. EPS $0.68 vs $0.69 Est., Sales $453.9M vs $455.9M Est.",2016-04-26 16:57:00-04:00,RMD,neutral
1095057.0,"Barclays Initiates Coverage on ResMed at Underweight, Announces $55.00 PT",2016-04-07 04:24:00-04:00,RMD,neutral
1095058.0,Resmed Increases Size Of Credit Facility From $700M To $1B,2016-04-04 16:12:00-04:00,RMD,positive
1095059.0,The Most Notable Insider Buys And Sells Of Last Week,2016-03-07 16:53:00-05:00,RMD,neutral
1095060.0,"ResMed Announces $800 Million Acquisition Of Brightree, Notes Transaction Adds To Its Global Leadership Position",2016-02-23 08:04:00-05:00,RMD,neutral
1095061.0,Barclays Terminates undefined Rating on ResMed,2016-02-23 03:51:00-05:00,RMD,neutral
1095062.0,UPDATE: ResMed's Brightree Acquisition to be Accretive To Gross Margins & Non-GAAP Earnings,2016-02-22 16:10:00-05:00,RMD,negative
1095063.0,ResMed To Acquire Brightree For $800M,2016-02-22 16:09:00-05:00,RMD,neutral
1095064.0,"Credit Suisse Upgrades ResMed to Outperform, Raises PT to $8.70",2016-01-22 09:48:00-05:00,RMD,positive
1095065.0,"Earnings Recap For January 21, 2016",2016-01-21 16:34:00-05:00,RMD,neutral
1095066.0,"ResMed Reports Q2 EPS $0.69 vs. Est. $0.66, Rev. $454.5M vs. Est. $446.25M",2016-01-21 16:06:00-05:00,RMD,neutral
1095067.0,"Earnings Scheduled For January 21, 2016",2016-01-21 04:05:00-05:00,RMD,neutral
1095068.0,Benzinga's Top Downgrades,2016-01-19 09:30:00-05:00,RMD,positive
1095069.0,"Barclays Downgrades ResMed to Underweight, Lowers PT to $52.00",2016-01-19 05:33:00-05:00,RMD,negative
1095070.0,ResMed to Acquire Inova Labs; Terms Not Disclosed -Reuters,2016-01-11 08:36:00-05:00,RMD,neutral
1095071.0,Needham Downgrades ResMed to Hold,2015-12-17 08:20:00-05:00,RMD,neutral
1095072.0,Resmed Selling Off; Hearing Cautious Northland Note on Reimbursement,2015-11-24 15:38:00-05:00,RMD,negative
1095073.0,ResMed Acquires Maribo Medico; Financial Terms Not Disclosed,2015-11-16 04:33:00-05:00,RMD,neutral
1095074.0,CareFusion AirLife Signs New Distribution Agreement with ResMed,2015-11-05 06:59:00-05:00,RMD,positive
1095075.0,ResMed Reports Q1 Adj EPS $0.58 Vs est $0.59,2015-10-22 16:27:00-04:00,RMD,neutral
1095076.0,Goldman Sachs Upgrades ResMed to Buy,2015-09-25 06:44:00-04:00,RMD,neutral
1095077.0,MKM Partners Would Sell These Healthcare Stocks On Weaker Relative Trends,2015-09-08 07:59:00-04:00,RMD,negative
1095078.0,Morgan Stanley Upgrades ResMed to Overweight,2015-07-31 09:55:00-04:00,RMD,negative
1095079.0,ResMed Acquires CareTouch; Terms Not Disclosed,2015-07-08 09:01:00-04:00,RMD,neutral
1095080.0,Leader In The 'Growing' Sleep-Disordered Breathing Market Might Be Worth An Investment,2015-06-25 08:22:00-04:00,RMD,positive
1095081.0,"Barclays Initiates Coverage on ResMed at Equal-weight, Announces $61.00 PT",2015-06-25 04:00:00-04:00,RMD,neutral
1095082.0,"Philips Also Checking Post Market Surveillance Data, Adverse Event & Other Published Data",2015-06-11 15:32:00-04:00,RMD,negative
1095083.0,Philips Evaluating Resmed Data To See IfIt Might Impact Patients Using AutoSV/BIPAP Advanced Devices,2015-06-11 15:31:00-04:00,RMD,positive
1095084.0,ResMed Shares Spike to High on Volume,2015-05-20 13:21:00-04:00,RMD,positive
1095085.0,Rhinomed Says Resmed to Sell Mute Snoring & Sleep Technology; Terms Not Disclosed,2015-05-14 21:37:00-04:00,RMD,neutral
1095086.0,Morning Market Losers,2015-05-13 09:59:00-04:00,RMD,negative
1095087.0,ResMed Trading Resumed; ResMed Short Sale Rule 201 In Effect,2015-05-13 09:41:00-04:00,RMD,neutral
1095088.0,"Resmed Serve-HF, Multinational, Multicenter, Randomized Controlled Phase III Trial Did Not Meet Its Primary Endpoint",2015-05-13 05:56:00-04:00,RMD,neutral
1095089.0,Goldman Sachs Downgrades ResMed to Neutral,2015-04-27 07:41:00-04:00,RMD,neutral
1095090.0,"CORRECTION: Macquarie Does Not Downgrade ATT to Neutral, Cuts ResMed From Outperform to Neutral",2015-04-27 06:14:00-04:00,RMD,negative
1095091.0,Macquarie Downgrades ResMed to Neutral,2015-04-27 06:13:00-04:00,RMD,neutral
1095092.0,Macquarie Downgrades ResMed to Neutral,2015-04-24 10:04:00-04:00,RMD,neutral
1095093.0,"ResMed Reports Inline Q3 Adj EPS $0.65, Sales $422.5M Vs Est $424.79M",2015-04-23 16:40:00-04:00,RMD,neutral
1095094.0,Credit Suisse Upgrades ResMed to Outperform,2015-04-07 08:15:00-04:00,RMD,positive
1095095.0,Citi Talks Obesity In Massive New Report,2015-03-25 07:53:00-04:00,RMD,neutral
1095096.0,Stocks Hitting 52-Week Highs,2015-03-18 10:08:00-04:00,RMD,neutral
1095097.0,"BBY Initiates Coverage on ResMed at Underperform, Announces $7.36 PT",2015-02-02 05:45:00-05:00,RMD,neutral
1095098.0,"Needham Upgrades ResMed to Buy, Announces $77.00 PT",2015-01-23 06:24:00-05:00,RMD,neutral
1095099.0,"ResMed Announces Q2 Revenue $423M vs $406.2M, EPS $0.64 vs $0.62",2015-01-22 16:08:00-05:00,RMD,neutral
1095100.0,ResMed Inc. Webcast Presentation Begins,2015-01-14 11:08:00-05:00,RMD,neutral
1095101.0,"Morgan Stanley Maintains Equal-weight on ResMed Inc., Raises PT to $52.39",2014-11-18 06:54:00-05:00,RMD,neutral
1095102.0,Top 4 NYSE Stocks In The Medical Appliances & Equipment Industry With The Highest Dividend Yield,2014-10-31 04:59:00-04:00,RMD,positive
1095103.0,UPDATE: Morgan Stanley Reiterates On ResMed Following 1Q15 Earnings Report,2014-10-24 10:12:00-04:00,RMD,neutral
1095104.0,Morning Market Movers ,2014-10-24 09:44:00-04:00,RMD,neutral
1095105.0,"Morgan Stanley Maintains Equal-weight on ResMed Inc., Raises PT to $49.57",2014-10-24 06:38:00-04:00,RMD,neutral
1095106.0,"ResMed Inc. Reports Q1 EPS of $0.58, Inline; Revenue of $380.40M vs $375.18M Est",2014-10-23 16:21:00-04:00,RMD,neutral
1095107.0,UPDATE: ResMed Says Negative Report Circulated Thursday is Anonymous and Misrepresents Itself as Legitimate Research,2014-10-09 17:56:00-04:00,RMD,negative
1095108.0,Resmed Shares Spike Lower; May be Attributed to Anonymous Fraud Report,2014-10-09 12:31:00-04:00,RMD,negative
1095109.0,ITC Judge Rules in ResMed's Favor in Patent Infringement Action Against BMC Medical,2014-08-24 17:23:00-04:00,RMD,negative
1095110.0,Qualcomm Announces New Connected Health Collaborations at Connect 2014,2014-08-12 07:33:00-04:00,RMD,neutral
1095111.0,ResMed Inc. Reports Q2 EPS of $0.64 vs $0.66 Est; Revenue of $415.20M vs $433.34M Est,2014-07-31 17:16:00-04:00,RMD,neutral
1095112.0,"UPDATE: ResMed Receives Permanent Injunction Against APEX In Germany, Continues Enforcement Of Patents in Europe",2014-07-28 08:05:00-04:00,RMD,neutral
1095113.0,ResMed Announces Permanent Injunction Against APEX in Germany,2014-07-28 08:05:00-04:00,RMD,neutral
1095114.0,"Option Alert: ResMed Aug $55 Call, 4,377 Contracts Traded vs 0 OI; Currently $49.49",2014-07-10 14:55:00-04:00,RMD,positive
1095115.0,UPDATE: Deutsche Bank Downgrades ResMed Following CMS Release,2014-07-03 10:19:00-04:00,RMD,neutral
1095116.0,"Deutsche Bank Downgrades ResMed Inc. to Hold, Maintains $52.00 PT",2014-07-03 09:13:00-04:00,RMD,neutral
1095117.0,Barron's Recap: The World's Most Respected Companies,2014-06-30 06:09:00-04:00,RMD,positive
1095118.0,JP Morgan Says ResMed Bundling Issue Is Less Of A Problem,2014-06-10 13:15:00-04:00,RMD,neutral
1095119.0,JP Morgan Upgrades ResMed Inc. to Overweight,2014-06-10 10:20:00-04:00,RMD,neutral
1095120.0,Resmed Moves Higher on Volume,2014-06-10 10:19:00-04:00,RMD,neutral
1095121.0,Judge Rules Taiwanese Firm Infringes on ResMed,2014-06-04 16:22:00-04:00,RMD,neutral
1095122.0,UPDATE: Northland Downgrades ResMed,2014-05-27 12:43:00-04:00,RMD,neutral
1095123.0,Northland Securities Downgrades ResMed Inc. to Underperform,2014-05-27 07:35:00-04:00,RMD,positive
1095124.0,"Deutsche Bank Upgrades ResMed from Hold to Buy, Price Target Boosted from $48 to $52",2014-04-24 11:41:00-04:00,RMD,positive
1095125.0,"Morgan Stanley Maintains Equal-weight on ResMed Inc., Raises PT to $46.08",2014-04-24 07:23:00-04:00,RMD,neutral
1095126.0,ResMed Inc. Reports Q3 EPS of $0.63 vs $0.64 Est; Revenue of $397.80M vs $400.01M Est,2014-04-23 16:07:00-04:00,RMD,neutral
1095127.0,BMC Wins in a Patent Invalidity Case Against ResMed,2014-04-23 10:03:00-04:00,RMD,positive
1095128.0,JP Morgan Downgrades ResMed Inc. to Neutral,2014-02-28 07:49:00-05:00,RMD,positive
1095129.0,Form 8-K from Resmed Shows New 20M Share Buyback Plan,2014-02-27 13:44:00-05:00,RMD,positive
1095130.0,William Blair Downgrades ResMed Inc. to Market Perform,2014-01-24 08:29:00-05:00,RMD,neutral
1095131.0,Top Losers After Hours,2014-01-23 17:20:00-05:00,RMD,negative
1095132.0,ResMed Inc. Reports Q2 EPS of $0.60 vs $0.63 Est; Revenue of $384.30M vs $398.09M Est,2014-01-23 16:18:00-05:00,RMD,neutral
1095133.0,Mid-Afternoon Market Update: Markets Float Higher on Relatively Thin Volume,2013-10-25 15:22:00-04:00,RMD,neutral
1095134.0,Mid-Day Market Update: Microsoft Jumps On Upbeat Results; Synaptics Shares Decline,2013-10-25 12:43:00-04:00,RMD,positive
1095135.0,UPDATE: Deutsche Bank Downgraded ResMed on Disappointing Sales Forecast,2013-10-25 12:14:00-04:00,RMD,negative
1095136.0,Mid-Morning Market Update: Markets Open Higher; Procter & Gamble Net Profit Surges 7.6 percent,2013-10-25 10:42:00-04:00,RMD,positive
1095137.0,UBS Upgraded ResMed Inc. to Buy,2013-10-25 09:41:00-04:00,RMD,neutral
1095138.0,"Deutsche Bank Downgrades ResMed Inc. to Hold, Maintains PT at $54.00",2013-10-25 07:12:00-04:00,RMD,neutral
1095139.0,ResMed Inc. Reports Q3 EPS of $0.56 vs $0.58 Est; Revenue of $357.70M vs $371.40M Est,2013-10-24 16:07:00-04:00,RMD,neutral
1095140.0,Northland Securities Initiates Coverage on ResMed Inc. with Market Perform,2013-10-07 17:18:00-04:00,RMD,positive
1095141.0,Shaw Stockbroking Initiates Coverage on ResMed Inc. at Buy,2013-09-20 06:37:00-04:00,RMD,neutral
1095142.0,UPDATE: Bank of America Upgrades ResMed on Multiple Positive Factors,2013-08-26 11:50:00-04:00,RMD,positive
1095143.0,Bank of America Upgrades ResMed Inc. to Buy,2013-08-26 07:21:00-04:00,RMD,neutral
1095144.0,"ResMed Patent Infringement Case vs BMC Advances, ITC Will Investigate",2013-08-21 08:04:00-04:00,RMD,negative
1095145.0,Bloomberg First Word Reporting ResMed Patent Case Related to Sleep-Aid Patents Could Be Investigated,2013-08-19 15:33:00-04:00,RMD,neutral
1095146.0,UPDATE: Deutsche Bank Upgrades ResMed Following Solid 4Q13 Results,2013-08-02 08:53:00-04:00,RMD,positive
1095147.0,"Deutsche Bank Upgrades ResMed Inc. to Buy, Raises PT to $54.00",2013-08-02 06:25:00-04:00,RMD,neutral
1095148.0,ResMed Inc. Reports Q4 EPS of $0.62 vs $0.61 Est; Revenue of $414.60M,2013-08-01 16:07:00-04:00,RMD,neutral
1095149.0,UBS Upgraded ResMed from Neutral to Buy,2013-07-30 09:43:00-04:00,RMD,neutral
1095150.0,ResMed Takes New Action to Enforce Patents,2013-07-22 08:04:00-04:00,RMD,neutral
1095151.0,ResMed Wins Patent Fight Against APEX ,2013-07-18 17:52:00-04:00,RMD,positive
1095152.0,Needham Initiates Coverage on ResMed Inc. at Hold,2013-07-16 08:35:00-04:00,RMD,neutral
1095153.0,UPDATE: Deutsche Bank Raises PT on ResMed Following Competitive Bidding Funding Cuts,2013-06-27 09:34:00-04:00,RMD,negative
1095154.0,ResMed Takes Action to Enforce Patents Against BMC and 3B,2013-06-05 08:07:00-04:00,RMD,neutral
1095155.0,Goldman Sachs Added Resmed to Conviction Buy List,2013-04-26 09:37:00-04:00,RMD,neutral
1095156.0,ResMed Inc. Reports Q3 EPS of $0.58 vs $0.57 Est; Revenue of $383.60M vs $387.88M Est,2013-04-25 16:12:00-04:00,RMD,neutral
1095157.0,ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment,2013-04-25 08:01:00-04:00,RMD,positive
1095158.0,UPDATE: Bank of America Downgrades ResMed to Neutral on Valuation,2013-01-25 11:54:00-05:00,RMD,neutral
1095159.0,"UPDATE: Jefferies Reiterates Hold Rating, Raises PT on ResMed",2013-01-25 10:27:00-05:00,RMD,neutral
1095160.0,Bank of America Downgrades ResMed Inc. to Neutral,2013-01-25 09:17:00-05:00,RMD,neutral
1095161.0,"Jefferies Maintains Hold on ResMed Inc., Raises PT to $42.00",2013-01-25 09:14:00-05:00,RMD,neutral
1095162.0,ResMed Inc. Reports Q2 EPS of $0.53 vs $0.51 Est; Revenue of $376.50M vs $363.76M Est,2013-01-24 16:10:00-05:00,RMD,neutral
1095163.0,Two Stocks Benfitting From Loud Snorers,2012-12-19 14:06:00-05:00,RMD,neutral
1095164.0,"UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on ResMed",2012-10-29 11:21:00-04:00,RMD,neutral
1095165.0,"Jefferies & Company Maintains ResMed at Hold, Raises PT from $34 to $35",2012-10-29 08:31:00-04:00,RMD,neutral
1095166.0,ResMed Reports Q3 EPS $0.49 vs $0.46 Est; Revenues $339.7M vs $341.15M Est,2012-10-25 16:35:00-04:00,RMD,neutral
1095167.0,"Morgan Stanley Maintains ResMed at Overweight, Raises PT from $37.26 to $41.39",2012-08-31 06:45:00-04:00,RMD,negative
1095168.0,UPDATE: Commonwealth Bank Upgrades ResMed to Buy Following Q4 Beat  ,2012-08-07 08:49:00-04:00,RMD,neutral
1095169.0,CBA Upgrades ResMed from Hold to Buy,2012-08-07 05:50:00-04:00,RMD,neutral
1095170.0,"Feltl and Company Maintains ResMed at Hold, Raises PT from $35.75 to $40",2012-08-06 10:42:00-04:00,RMD,neutral
1095171.0,Credit Suisse Upgrades ResMed from Neutral to Outperform,2012-08-06 06:12:00-04:00,RMD,positive
1095172.0,Bank of America Upgrades ResMed from Neutral to Buy,2012-08-03 10:23:00-04:00,RMD,neutral
1095173.0,ResMed Reports Q4 EPS $0.53 vs $0.49 Est; Revenues $371.9M vs $368.86M Est,2012-08-02 16:39:00-04:00,RMD,neutral
1095174.0,"UPDATE: Morgan Stanley Reiterates Overweight Rating, Raises PT on ResMed",2012-08-01 09:47:00-04:00,RMD,negative
1095175.0,"Morgan Stanley Maintains ResMed at Overweight, Raises PT from $32.95 to $33.37",2012-08-01 09:01:00-04:00,RMD,negative
1095176.0,Feltl and Company Downgrades ResMed from Buy to Hold,2012-07-19 08:32:00-04:00,RMD,neutral
1095177.0,UPDATE: ResMed Announces Plan To Initiate Dividend of $0.17,2012-05-17 16:32:00-04:00,RMD,neutral
1095178.0,ResMed Announces Plan To Initiate Dividend; Update On Chief Executive Officer Succession ,2012-05-17 16:31:00-04:00,RMD,positive
1095179.0,Goldman Sachs Upgrades ResMed from Neutral to Buy,2012-04-27 09:22:00-04:00,RMD,neutral
1095180.0,JP Morgan Upgrades ResMed from Neutral to Overweight,2012-04-27 09:20:00-04:00,RMD,neutral
1095181.0,"Bank of America Downgrades ResMed from Buy to Neutral,  from $  to $ ",2012-04-27 09:09:00-04:00,RMD,neutral
1095182.0,"Feltl and Company Upgrades ResMed from Hold to Buy, Raises PT to $38",2012-04-27 09:08:00-04:00,RMD,neutral
1095183.0,"Jefferies & Company Maintains ResMed at Hold, Raises PT from $28 to $34",2012-04-27 07:08:00-04:00,RMD,neutral
1095184.0,ResMed Reports Q3 EPS $0.44 vs $0.41 Est; Revenues $349.1M vs $339.41M Est,2012-04-26 16:40:00-04:00,RMD,neutral
1095185.0,"Deutsche Bank Maintains ResMed at Buy, Raises PT from $32 to $33.65",2012-04-13 09:30:00-04:00,RMD,neutral
1095186.0,"Feltl and Company Downgrades ResMed from Buy to Hold, Maintains PT at $33.15",2012-03-28 09:12:00-04:00,RMD,neutral
1095187.0,Roth IRA Conversion 2012: Are You a Good Candidate?,2012-02-20 00:00:00-05:00,RMD,positive
1095188.0,"Three healthcare stocks I'm buying: Mako, ResMed and Centene",2012-02-13 03:46:00-05:00,RMD,neutral
1095189.0,UPDATE: Feltl & Company Downgrades ResMed to Buy,2012-02-06 10:59:00-05:00,RMD,neutral
1095190.0,UPDATE: Deutsche Bank Upgrades ResMed to Buy,2012-01-27 12:15:00-05:00,RMD,neutral
1095191.0,Deutsche Bank Upgrades ResMed to Buy,2012-01-27 06:09:00-05:00,RMD,neutral
1095192.0,ResMed Reports Q2 EPS $0.42 vs $0.38 Est; Revenues $332.7M vs $339.62M Est	 			,2012-01-26 16:10:00-05:00,RMD,neutral
1095193.0,Feltl and Company Downgrades ResMed to Buy,2012-01-17 08:59:00-05:00,RMD,neutral
1095194.0,Benzinga's Top Upgrades,2011-12-20 08:57:00-05:00,RMD,positive
1095195.0,UPDATE: Feltl and Company Upgrades RedMed to Strong Buy,2011-12-20 08:30:00-05:00,RMD,positive
1095196.0,Feltl and Company Upgrades ResMed to Strong Buy,2011-12-20 08:27:00-05:00,RMD,positive
1095197.0,ResMed Hits 52-Week Low of $23.53,2011-12-14 09:31:00-05:00,RMD,negative
1095198.0,ResMed Hits 52-Week Low of $24.57,2011-12-13 10:36:00-05:00,RMD,negative
1095199.0,ResMed Hits 52-Week Low of $25.27,2011-11-23 09:32:00-05:00,RMD,negative
1095200.0,ResMed Hits 52-Week Low of $25.71,2011-11-22 09:31:00-05:00,RMD,negative
1095201.0,UPDATE: Jefferies Lowers Price Target on ResMed to $28,2011-10-25 09:37:00-04:00,RMD,negative
1095202.0,Piper Jaffray Lowers PT to $33 on ResMed,2011-10-25 07:27:00-04:00,RMD,negative
1095203.0,ResMed Reports Q1 EPS $0.33 vs $0.35 Est; Revenues $314.8M vs $326.32M Est			,2011-10-24 16:10:00-04:00,RMD,neutral
1095204.0,Bank of America Merrill Lynch Maintains Buy on ResMed,2011-08-31 07:19:00-04:00,RMD,neutral
1095205.0,ResMed Appoints New COO; Announces $20M Share Buyback,2011-08-30 16:15:00-04:00,RMD,positive
1095206.0,Notable Call Options Activity in ResMed,2011-08-17 11:52:00-04:00,RMD,neutral
1095207.0,Piper Jaffray Comments On ResMed 4Q11,2011-08-05 09:47:00-04:00,RMD,neutral
1095208.0,Piper Jaffray Lowers PT on ResMed To $36,2011-08-05 06:43:00-04:00,RMD,negative
1095209.0,ResMed Reports Q4 EPS $0.37 vs $0.36 Est; Revenues $341.9M vs $334.78M Est				,2011-08-04 16:09:00-04:00,RMD,neutral
1095210.0,Options Brief: ResMed,2011-08-02 10:16:00-04:00,RMD,neutral
1095212.0,Piper Jaffray Reiterates Overweight On ResMed,2011-07-06 13:09:00-04:00,RMD,negative
1095213.0,ResMed Announces Acquisition of BiancaMed ,2011-07-06 08:04:00-04:00,RMD,neutral
1095214.0,Wednesday's Put/Call Ratio Leaders,2011-06-29 13:54:00-04:00,RMD,neutral
1095215.0,ResMed Reports EPS of $0.34 vs. $0.35 Estimate; Revenues $313.3M vs. $311.56M Estimate,2011-04-28 16:10:00-04:00,RMD,neutral
1095216.0,Morgan Stanley Overweight On Resmed Inc. (RMD),2011-04-27 07:28:00-04:00,RMD,negative
1095217.0,Jefferies Previews ResMeds' Earnings (RMD),2011-04-14 07:55:00-04:00,RMD,neutral
1095218.0,Piper Jaffray Maintains Overweight On ResMed Inc.  (RMD),2011-04-14 07:24:00-04:00,RMD,negative
1095219.0,Piper Jaffray Maintains OW Rating On RMD,2011-04-06 07:22:00-04:00,RMD,neutral
1095220.0,"Top 4 Large-Cap Stocks In The Medical Appliances & Equipment Industry With The Lowest PEG Ratio (RBCN, STJ, ZMH, MDT)",2011-04-05 00:40:00-04:00,RMD,negative
1095221.0,"Biodefense Stocks/ Homeland Defense Stock Alert; Dynasil Corporation trading at $6.26, up 2.50 (66.49%)",2011-03-23 14:17:00-04:00,RMD,positive
1095222.0,Homeland Defense Stocks; Dynasil Corporation (NASDAQ GM:DYSL) Announces Patent Approvals For Advanced Radiation Detection and Increased Detector Production Capacity,2011-03-23 09:00:00-04:00,RMD,positive
1095223.0,Homeland Defense Stocks; Dynasil Corporation (NASDAQ GM:DYSL) Announces Patent Approvals For Advanced Radiation Detection and Increased Detector Production Capacity,2011-03-23 09:00:00-04:00,RMD,positive
1095224.0,ResMed Inc. Announces CEO Resignation ,2011-02-01 08:40:00-05:00,RMD,negative
1095225.0,"Piper Jaffray Maintains ResMed Overweight Rating, $38 PT (RMD)",2011-01-28 09:53:00-05:00,RMD,negative
1095226.0,Jefferies Maintains Hold on ResMed (RMD),2011-01-28 07:27:00-05:00,RMD,neutral
1095227.0,ResMed Reports Q2 EPS of $.37 vs. $.36,2011-01-27 16:35:00-05:00,RMD,neutral
1095228.0,"ResMed Inc. Announces Record Financial Results for the Quarter Ended and Six Months Ended December 31, 2010",2011-01-27 16:09:00-05:00,RMD,neutral
1095229.0,ResMed 2Q11 Previewed by Piper Jaffray,2011-01-26 13:51:00-05:00,RMD,neutral
1095230.0,ResMed Earnings To Be Reported On January 28,2011-01-24 09:01:00-05:00,RMD,neutral
1095231.0,"ResMed Top-Line And Gross Profits Indicative Of Continued Strength, Jefferies & Company Reports",2010-10-29 08:40:00-04:00,RMD,positive
1095232.0,Encouraging Results from ResMed - Analyst Blog,2010-09-17 11:06:00-04:00,RMD,positive
1095233.0,ResMed Inc. Announces Completion of Stock Split ,2010-09-08 16:01:00-04:00,RMD,neutral
1095234.0,Morgan Stanley Upgrades RMD To Overweight,2010-09-07 06:18:00-04:00,RMD,negative
1095235.0,Citigroup Places Buy Rating on ResMed (RMD),2010-09-03 08:29:00-04:00,RMD,neutral
1095236.0,ResMed Remains Comfortable Pricing Products At A 5%-10% Premium To The Competition,2010-08-13 13:28:00-04:00,RMD,positive
1095237.0,"JP Morgan Reiterates Overweight Rating For ResMed, Inc.",2010-08-13 10:24:00-04:00,RMD,neutral
1095238.0,Citi Maintains Buy Rating On ResMed Inc (RMD),2010-08-12 08:05:00-04:00,RMD,neutral
1095239.0,ResMed Beats Estimates - Analyst Blog,2010-08-09 17:52:00-04:00,RMD,neutral
1095240.0,ResMed Reports Earnings/Stock Split (RMD),2010-08-05 16:19:00-04:00,RMD,neutral
1095241.0,William Blair Reiterates Outperform Rating on ResMed (RMD),2010-07-26 09:26:00-04:00,RMD,neutral
1095242.0,Big Money Yet to Buy Into July Rally  07-12-2010,2010-07-12 18:40:00-04:00,RMD,neutral
1095243.0,"Top 4 Stocks In The Medical Appliances And Equipment Industry With The Highest Profit Margin (ISRG, MDT, MASI, RMD)",2010-07-06 07:00:00-04:00,RMD,positive
1095244.0,Resmed Ind. (RMD) Moves To A New Three Year High,2010-02-08 10:43:00-05:00,RMD,neutral
